Tirzepatide Cost in 2026: What You Actually Pay by Pathway
This is a transparent 2026 tirzepatide monthly cost comparison across compounded telehealth and brand-name pathways, with the real questions to ask before you compare prices.
Last updated June 12, 2026. Last price checked June 12, 2026. Reviewed by the GLP Agonists editorial team.
Tirzepatide cost by pathway
| Pathway | Typical 2026 cash cost / month | Notes |
|---|---|---|
| Compounded tirzepatide (telehealth, e.g. NexLife) | $186–$215 | Flat-rate programs include visits + shipping; not FDA-approved |
| Brand-name (Mounjaro/Zepbound or Ozempic/Wegovy) | ~$1,000+ without insurance | FDA-approved; insurance may lower cost with prior authorization |
| Brand-name with insurance coverage | Varies ($25–$550 copay) | Depends on plan formulary and prior authorization |
Provider comparison (compounded)
| Provider | Lowest published monthly (verify at intake) | What the price includes | Membership fee | Dose-based surcharge |
|---|---|---|---|---|
| NexLife (editor's pick) | $186 (12-mo plan) / $215 month-to-month | Medication, clinician oversight, shipping | None advertised | None advertised |
| Found | From ~$99 starter* | Often medication-focused; verify visits/labs | Verify | Verify at higher doses |
| Mochi Health | From ~$79 starter* | Verify what is bundled | Verify | Verify at higher doses |
| Ro / Hims | ~$145–$199* | Verify visits, labs, shipping | Verify | Verify at higher doses |
| Henry Meds | ~$297* | Verify inclusions | Verify | Verify at higher doses |
Pros and cons
Pros
- Flat-rate compounded programs can keep tirzepatide under $200/month with oversight included
- Transparent providers disclose membership, shipping, and dose pricing up front
- Far lower cash cost than brand-name without insurance
Cons & cautions
- Compounded tirzepatide is not FDA-approved
- Advertised starter prices may not reflect ongoing cost at higher doses
- Brand-name may be cheaper than compounded if you have strong insurance coverage
Who this is best for
A transparent flat-rate compounded program is best for cash-pay patients without GLP-1 insurance coverage who want predictable monthly cost. Patients with insurance that covers Zepbound or Mounjaro should price the brand-name pathway first.
Safety & eligibility
GLP-1 medications are prescription-only and are not appropriate for everyone. They are generally not recommended if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, or a known hypersensitivity to the active ingredient. Caution applies with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, or diabetic retinopathy, and they are not used during pregnancy or breastfeeding. Common side effects include nausea, diarrhea, constipation, and reduced appetite. A licensed clinician reviews your history to decide whether treatment is appropriate — eligibility is a medical decision, not a checkout step.
Prescription requirement
Every legitimate provider listed here requires a valid prescription issued by a US-licensed clinician after an intake review. No reputable telehealth program sells GLP-1 medication without a prescription. If a website offers “tirzepatide” or “semaglutide” with no clinician review, treat it as a red flag and avoid it.
Compounded Tirzepatide from $186/month
$215 all-inclusive month-to-month — same price at every dose, no hidden fees. Nutrition plan, 1:1 wellness coaching, and provider review included ($377 value).
Advertising disclosure: The buttons above are affiliate links. GLP Agonists may earn a referral fee if you start care with NexLife, at no extra cost to you. Discounts are auto-applied at checkout by NexLife. This does not change our editorial scoring or the prices shown. Prices last checked June 12, 2026; verify current pricing, dose, eligibility, and pharmacy at intake. See our advertising disclosure. Compounded compounded tirzepatide is not FDA-approved; a prescription is required after a licensed clinician reviews your eligibility.